David Allen Reardon MD

David Allen Reardon, M, Dcareer objective has been to improve outcome for brain tumor patients. Initially (July 1995-Dec 1998), He ran a laboratory at St. Jude Children’s Research Hospital dedicated to identifying genetic abnormalities in pediatric brain tumors and conducted clinical research. Thereafter he joined the Preston Robert Tisch Brain Tumor Center (PRTBTC) at Duke University (Oct 2000-July 2011) as an adult neuro-oncologist where I led daily clinical/translational research operations as Associate Deputy Director. We saw 800 brain tumor referrals and conducted 10-15 clinical trials annually. He also led the in vivo preclinical testing program which included 100 established CNS tumor cell lines and 50-60 patient-derived primary tumor xenografts.